CTRI/2024/08/072312
Not yet recruiting
未知
Evaluation of Optical Coherence Tomography Angiography Parameters following use of Anti vascular endothelial growth factor in Non resolving Central Serous Chorioretinopathy - NIl
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Maulana Azad Medical college
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\)Treatment naïve subjects in the age group of 25\-50 years having non resolving central serous chrioretinopathy of more than four months duration along with subretinal fluid (SRF) involving fovea on optical coherence topography (oct) and active angiographic leakage of fundus fluorescein angiography (FFA)
- •2\)Subject having best corrected visual acuity (BCVA) of at least 6/60
Exclusion Criteria
- •1\)patients having ocular conditions causing accumulation of sub\-retinal fluid like diabetic retinopathy,retinal vascular occlusion,ocular inflammation or ocular conditions causing macular exudation such as pathological myopia and antioxidants streaks
- •2\)patients who have undergone any intraocular surgery other than uncomplicated cataract extraction
- •3\)Risk of thrombo\-emboli events and/or occurrence within past 6 months
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
Evaluation of OCTA after giving AntiVEGF in BRVO patientsCTRI/2024/08/072313Maulana Azad Medical College
Not yet recruiting
Not Applicable
evaluation of OCTA following use of antiVEGF in retinal disease of eye in patients above 50 yrsCTRI/2023/03/050175MAULANA AZAD MEDICAL COLLEGE
Not yet recruiting
Not Applicable
Evaluation of OCTA following use of Anti VEGF in retinal disease of eye in diabetic patientsHealth Condition 1: H350- Background retinopathy and retinalvascular changesCTRI/2023/04/051257Maulana Azad Medical College
Recruiting
Not Applicable
Optical coherence tomography angiography in healthy subjects and patients with retinal vascular diseases.Retinal vascular diseasesACTRN12617001633370lions eye institute300
Not yet recruiting
Not Applicable
Evaluation of OCTA parameters in CSCRCTRI/2021/09/036966KAVYA C RAO